Figure 4.

EV-miR-23b inhibits inflammation response in BV2 cells. (a) RT-qPCR analysis of miR-23b expression in BV2 cells; (b) MTT assay for BV2 cell viability; (c) ELISA for IL-6, IL1β, TNFα, and IL10 protein concentration in BV2 cells; (d) Western blot analysis for iNOS and Arg1 protein expression in BV2 cells. The cell experiment was repeated three times. Data are expressed as mean ± standard deviation and analyzed using one-way ANOVA and Tukey’s multiple comparisons test, *p < 0.05, **p < 0.01